<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rsp</journal-id><journal-title-group><journal-title xml:lang="ru">Научно-практическая ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Rheumatology Science and Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-4484</issn><issn pub-type="epub">1995-4492</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47360/1995-4484-2022-495-500</article-id><article-id custom-type="elpub" pub-id-type="custom">rsp-3205</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЙ СЛУЧАЙ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL OBSERVATION</subject></subj-group></article-categories><title-group><article-title>Тяжелый миокардит как причина формирования кардиоренального синдрома у больной рефрактерным ревматоидным артритом</article-title><trans-title-group xml:lang="en"><trans-title>Severe myocarditis as a cause of the formation of cardiorenal syndrome in a patient with refractory rheumatoid arthritis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5809-6015</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мутовина</surname><given-names>З. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Mutovina</surname><given-names>Z. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>121359, Москва, ул. Маршала Тимошенко, 19, стр. 1А;</p><p>123182, Москва, ул. Пехотная, 3</p></bio><bio xml:lang="en"><p>121359, Moscow, Marshala Timoshenko str., 19, building 1A;</p><p>123182, Moscow, Pekhotnaya str., 3</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9820-8851</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гордеев</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gordeev</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>121359, Москва, ул. Маршала Тимошенко, 19, стр. 1А;</p><p>115522, Москва, Каширское шоссе, 34а</p></bio><bio xml:lang="en"><p>121359, Moscow, Marshala Timoshenko str., 19, building 1A;</p><p>115522, Moscow, Kashirskoye Highway, 34A</p></bio><email xlink:type="simple">avg1305@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Розанова</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Rozanova</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>121356, Москва, ул. Маршала Тимошенко, 15</p></bio><bio xml:lang="en"><p>121356, Moscow, Marshala Timoshenko str., 15</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2776-4276</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Галушко</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Galushko</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>115522, Москва, Каширское шоссе, 34а</p></bio><bio xml:lang="en"><p>115522, Moscow, Kashirskoye Highway, 34A</p></bio><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ ДПО «Центральная государственная медицинская академия» Управления делами Президента Российской Федерации;&#13;
ГБУЗ города Москвы «Городская клиническая больница № 52 Департамента здравоохранения города Москвы»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central State Medical Academy of the Administrative Directorate of the President of the Russian Federation;&#13;
City Clinical Hospital N 22, Moscow Healthcare Department</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ ДПО «Центральная государственная медицинская академия» Управления делами Президента Российской Федерации;&#13;
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central State Medical Academy of the Administrative Directorate of the President of the Russian Federation;&#13;
V.A. Nasonova Research Institute of Rheumatology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБУ «Центральная клиническая больница с поликлиникой» Управления делами Президента Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central Clinical Hospital of the Administrative Directorate of the President of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.A. Nasonova Research Institute of Rheumatology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>07</day><month>09</month><year>2022</year></pub-date><volume>60</volume><issue>4</issue><fpage>495</fpage><lpage>500</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мутовина З.Ю., Гордеев А.В., Розанова И.В., Галушко Е.А., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Мутовина З.Ю., Гордеев А.В., Розанова И.В., Галушко Е.А.</copyright-holder><copyright-holder xml:lang="en">Mutovina Z.Y., Gordeev A.V., Rozanova I.V., Galushko E.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://rsp.mediar-press.net/rsp/article/view/3205">https://rsp.mediar-press.net/rsp/article/view/3205</self-uri><abstract><p>Согласно современным представлениям, миокардит – это воспалительное заболевание миокарда, диагностируемое на основании общепринятых гистологических, иммунологических, иммуногистохимических критериев. Ранее большинство исследователей считали наиболее распространенным кардиальным внесуставным проявлением ревматоидного артрита (РА) перикардит. Позднее с помощью магнитно-резонансной томографии (МРТ) сердца было показано, что миокардит у пациентов с РА не является редким проявлением болезни. В последнее время появляется все больше доказательств того, что воспалительные цитокины при РА могут также вызывать хроническое повреждение миокарда, способствуя развитию хронической сердечной недостаточности (ХСН). В нашем клиническом случае миокардит развился у пациентки с активным рефрактерным РА. Поражение миокарда у нее характеризовалось выраженными эхокардиографическими признаками рестриктивной кардиомиопатии, значительным снижением фракции выброса с развитием сердечной недостаточности, различными нарушениями ритма в сочетании с острым нарушением функции почек, что привело к формированию кардиоренального синдрома (КРС). Полный регресс ревматоидного миокардита и КРС наблюдался на фоне корректно подобранного эффективного лечения рефрактерного РА базисными противовоспалительными препаратами и успешного использования генно-инженерного биологического препарата. </p></abstract><trans-abstract xml:lang="en"><p>According to modern concepts, myocarditis is an inflammatory disease of the myocardium, diagnosed on the basis of generally accepted histological, immunological, immunohistochemical criteria. Previously, most researchers believed that the most common cardiac extra-articular manifestation of rheumatoid arthritis (RA) is pericarditis. In the last decade, using magnetic resonance imaging (MRI) of the heart, it turned out that myocarditis in patients with rheumatoid arthritis is not a rare manifestation of the disease. Recently, there is increasing evidence that inflammatory cytokines in RA can also directly cause chronic myocardial damage, further contributing to the development of chronic heart failure (CHF). In our clinical case, myocarditis developed in a patient with active refractory rheumatoid arthritis. The myocardial lesion in the patient was characterized by pronounced echocardiographic signs of restrictive cardiomyopathy, a significant decrease in the ejection fraction with the development of heart failure, various rhythm disturbances in combination with acute renal dysfunction, which led to the formation of cardiorenal syndrome (CRS). Complete regression of myocarditis and cattle occurred precisely against the background of effective treatment of refractory rheumatoid arthritis (RA) with basic antirheumatic drugs and the successful use of biological therapy. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>миокардит</kwd><kwd>рестриктивная кардиомиопатия</kwd><kwd>рефрактерный ревматоидный артрит</kwd><kwd>ренокардиальный синдром</kwd><kwd>сердечно-сосудистые заболевания</kwd></kwd-group><kwd-group xml:lang="en"><kwd>myocarditis</kwd><kwd>restrictive cardiomyopathy</kwd><kwd>refractory rheumatoid arthritis (RRA)</kwd><kwd>renocardial syndrome</kwd><kwd>cardiovascular diseases (CVD)</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Статья подготовлена в рамках научной темы «Разработка персонализированной программы лечения рефрактерного ревматоидного артрита на основе изучения молекулярно-генетических и молекулярно-биологических предикторов. Создание и апробация регистра пациентов с ревматоидным артритом, резистентных к базисной противовоспалительной терапии» (№ АААА-А19-119021190149-0). Исследование не имело спонсорской поддержки.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, et al. Report of the 1995 World Health Organization/ International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation. 1996;93(5):841-842. doi: 10.1161/01.cir.93.5.841</mixed-citation><mixed-citation xml:lang="en">Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, et al. Report of the 1995 World Health Organization/ International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation. 1996;93(5):841-842. doi: 10.1161/01.cir.93.5.841</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Насонов ЕЛ. Достижения ревматологии в XXI веке. Научнопрактическая ревматология. 2014;52(2):133140. doi: 10.14412/1995-4484-2014-133-140</mixed-citation><mixed-citation xml:lang="en">Nasonov EL. Achievements in rheumatology in the XXI century. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2014; 52(2):133-140 (In Russ.). doi: 10.14412/1995-4484-2014-133-140</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Caforio AL, Pankuweit S, Arbustini E, Basso C, GimenoBlanes J, Felix SB, et al.; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636-2648, 2648a-2648d. doi: 10.1093/eurheartj/eht210</mixed-citation><mixed-citation xml:lang="en">Caforio AL, Pankuweit S, Arbustini E, Basso C, GimenoBlanes J, Felix SB, et al.; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636-2648, 2648a-2648d. doi: 10.1093/eurheartj/eht210</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Немчинов ЕН, Крель АА. Ревматоидное поражение сердца. Терапевтический архив. 1986;12:126-134.</mixed-citation><mixed-citation xml:lang="en">Nemchinov EN, Krel AA. Rheumatoid heart disease. Terapevticheskiy arkhiv. 1986;12:126-134 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Turesson C, Jacobsson L, Bergström U. Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford). 1999;38(7):668-674. doi: 10.1093/rheumatology/38.7.668</mixed-citation><mixed-citation xml:lang="en">Turesson C, Jacobsson L, Bergström U. Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford). 1999;38(7):668-674. doi: 10.1093/rheumatology/38.7.668</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kobayashi Y, Giles JT, Hirano M, Yokoe I, Nakajima Y, Bathon JM, et al. Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: A pilot study. Arthritis Res Ther. 2010;12(5): R171. doi: 10.1186/ar3131</mixed-citation><mixed-citation xml:lang="en">Kobayashi Y, Giles JT, Hirano M, Yokoe I, Nakajima Y, Bathon JM, et al. Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: A pilot study. Arthritis Res Ther. 2010;12(5): R171. doi: 10.1186/ar3131</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mavrogeni S, Bratis K, Sfendouraki E, Papadopoulou E, Kolovou G. Myopericarditis, as the first sign of rheumatoid arthritis relapse, evaluated by cardiac magnetic resonance. Inflamm Allergy Drug Targets. 2013;12(3):206-211. doi: 10.2174/1871528111312030008</mixed-citation><mixed-citation xml:lang="en">Mavrogeni S, Bratis K, Sfendouraki E, Papadopoulou E, Kolovou G. Myopericarditis, as the first sign of rheumatoid arthritis relapse, evaluated by cardiac magnetic resonance. Inflamm Allergy Drug Targets. 2013;12(3):206-211. doi: 10.2174/1871528111312030008</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ntusi NAB, Piechnik SK, Francis JM, Ferreira VM, Matthews PM, Robson MD, et al. Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: Insights from CMR T1 mapping. JACC Cardiovasc Imaging. 2015;8(5):526-536. doi: 10.1016/j.jcmg.2014.12.025</mixed-citation><mixed-citation xml:lang="en">Ntusi NAB, Piechnik SK, Francis JM, Ferreira VM, Matthews PM, Robson MD, et al. Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: Insights from CMR T1 mapping. JACC Cardiovasc Imaging. 2015;8(5):526-536. doi: 10.1016/j.jcmg.2014.12.025</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Puntmann VO, Taylor PC, Barr A, Schnackenburg B, Jahnke C, Paetsch I. Towards understanding the phenotypes of myocardial involvement in the presence of self-limiting and sustained systemic inflammation: A magnetic resonance imaging study. Rheumatology (Oxford). 2010;49(3):528-535. doi: 10.1093/rheumatology/kep426</mixed-citation><mixed-citation xml:lang="en">Puntmann VO, Taylor PC, Barr A, Schnackenburg B, Jahnke C, Paetsch I. Towards understanding the phenotypes of myocardial involvement in the presence of self-limiting and sustained systemic inflammation: A magnetic resonance imaging study. Rheumatology (Oxford). 2010;49(3):528-535. doi: 10.1093/rheumatology/kep426</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bradham WS, Bozkurt B, Gunasinghe H, Mann D, Spinale FG. Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: A current perspective. Cardiovasc Res. 2002;53(4):822-830. doi: 10.1016/s0008-6363(01)00503-x</mixed-citation><mixed-citation xml:lang="en">Bradham WS, Bozkurt B, Gunasinghe H, Mann D, Spinale FG. Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: A current perspective. Cardiovasc Res. 2002;53(4):822-830. doi: 10.1016/s0008-6363(01)00503-x</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Spinale FG, Coker ML, Heung LJ, Bond BR, Gunasinghe HR, Etoh T, et al. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation. 2000;102(16):1944- 1949. doi: 10.1161/01.cir.102.16.1944</mixed-citation><mixed-citation xml:lang="en">Spinale FG, Coker ML, Heung LJ, Bond BR, Gunasinghe HR, Etoh T, et al. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation. 2000;102(16):1944- 1949. doi: 10.1161/01.cir.102.16.1944</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, et al. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial. ATTRACT Study Group. Lancet. 1999;354(9194): 1932-1939. doi: 10.1016/s0140-6736(99)05246-0</mixed-citation><mixed-citation xml:lang="en">Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, et al. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial. ATTRACT Study Group. Lancet. 1999;354(9194): 1932-1939. doi: 10.1016/s0140-6736(99)05246-0</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52(19):1527-1539. doi: 10.1016/j.jacc.2008.07.051</mixed-citation><mixed-citation xml:lang="en">Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52(19):1527-1539. doi: 10.1016/j.jacc.2008.07.051</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Jose P, Skali H, Anavekar N, Tomson C, Krumholz HM, Rouleau JL, et al. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol. 2006;17(10):2886-2891. doi: 10.1681/ASN.2006010063</mixed-citation><mixed-citation xml:lang="en">Jose P, Skali H, Anavekar N, Tomson C, Krumholz HM, Rouleau JL, et al. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol. 2006;17(10):2886-2891. doi: 10.1681/ASN.2006010063</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Cowie MR, Komajda M, Murray-Thomas T, Underwood J, Ticho B; POSH Investigators. Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: Results of the prospective outcomes study in heart failure (POSH). Eur Heart J. 2006;27(10):1216-1222. doi: 10.1093/eurheartj/ehi859</mixed-citation><mixed-citation xml:lang="en">Cowie MR, Komajda M, Murray-Thomas T, Underwood J, Ticho B; POSH Investigators. Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: Results of the prospective outcomes study in heart failure (POSH). Eur Heart J. 2006;27(10):1216-1222. doi: 10.1093/eurheartj/ehi859</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ronco C. Cardiorenal and renocardiac syndromes: Clinical disorders in search of a systematic definition. Int J Artif Organs. 2008;31(1):1-2. doi: 10.1177/039139880803100101</mixed-citation><mixed-citation xml:lang="en">Ronco C. Cardiorenal and renocardiac syndromes: Clinical disorders in search of a systematic definition. Int J Artif Organs. 2008;31(1):1-2. doi: 10.1177/039139880803100101</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Гордеев АВ, Галушко ЕА, Насонов ЕЛ. Концепция мультиморбидности в ревматологической практике. Научно-практическая ревматология. 2014;52(4):362365. doi: 10.14412/1995-4484-2014-362-365</mixed-citation><mixed-citation xml:lang="en">Gordeev AV, Galushko EA, Nasonov EL. The concept of multimorbidity in rheumatologic practice. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2014;52(4):362-365 (In Russ.). doi: 10.14412/1995-4484-2014-362-365</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Мутовина ЗЮ, Загребнева АИ, Галушко ЕА, Гордеев АВ. Кардиоренальный синдром у больных ревматоидным артритом. Современная ревматология. 2019;13(3):82-86. doi: 10/14412/1996-7012-2019-3-82-86</mixed-citation><mixed-citation xml:lang="en">Mutovina ZYu, Zagrebneva AI, Galushko EA, Gordeev AV. Cardiorenal syndrome in patients with rheumatoid arthritis. Modern Rheumatology Journal. 2019;13(3):82-86 (In Russ.). doi: 10/14412/1996-7012-2019-3-82-86</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
